CDER Laments Lack Of Shortage Funding, But FDA Didn’t Request New Money For 2024

 
• By Sarah Karlin-Smith

CDER head is worried FDA won’t be able to sustain gains the agency made on drug shortages and supply chain work as big CARES Act boost set to run out this year, yet it didn’t ask Congress for new taxpayer funding in the fiscal year 2024 budget request.

PS2304_cavazzoni_drug_shortage
Director Patrizia Cavazzoni said FDA has money to pay inspectors, but has seen 'a lot of attrition.' • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Distribution/Supply Chain

More from Compliance